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Abstract
The brain requires vast amounts of energy to carry out neurotransmission; 
indeed, it is responsible for approximately one-fifth of the body’s energy consump-
tion. Therefore, in order to understand functions of brain cells under both normal 
and pathological conditions, it is critical to elucidate dynamics of intracellular 
energy. The mitochondrion is the key intercellular organelle that controls neuronal 
energy and survival. Numerous studies have reported a correlation between altered 
mitochondrial function and brain-associated diseases; thus mitochondria may 
serve as a promising target for treating these conditions. In this chapter, we will 
discuss the mechanisms of mitochondrial production, movement, and degradation 
in order to understand accessibility of energy during physiological and pathological 
conditions of the brain. While research targeting molecular dynamics is promis-
ing, translation into clinical relevance based on bench research is challenging. For 
these reasons, we will also summarize lifestyle factors, including interventions 
and chronic comorbidities that disrupt mitochondrial dynamics. By determining 
lifestyle factors that are readily accessible, we can propose a new viewpoint for a 
synergistic and translational approach for neuroprotection.
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1. Introduction
Frequently referred to as the “the powerhouse of the cell,” the mitochondrion 
is the key organelle that contributes to neuronal energy and viability through 
the production of adenosine triphosphate (ATP) via oxidative phosphorylation. 
During oxidative phosphorylation, electrons from FADH2 or NADH travel across 
the electron transport chain (ETC) creating an electrical gradient along the inner 
mitochondrial membrane allowing protons to diffuse through the ATP synthase. 
This allows the ATP synthase to bind a phosphate group to adenosine diphosphate 
(ADP) creating ATP. Compared to other metabolic pathways such as fermentation 
and anaerobic respiration, oxidative phosphorylation is the most efficient process 
to generate ATP. Energy in the brain is used for overall maintenance of cellular 
processes, neuronal growth, and axonal branching [1]. However, a majority of the 
ATP produced is utilized to support one of the neuron’s most essential functions, 
synaptic transmission [2]. For example, the Na+, K+ -ATPase or the Na+, K+-pump is 
responsible for approximately half of the energy consumed by the brain, through its 
use of active transport to pump out sodium ions while taking in potassium ions [3]. 
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This pump is essential in neurotransmission through its regulation of membrane 
potential, cell volume, and intracellular Ca2+ homeostasis [4, 5]. Likewise, exocy-
tosis requires sufficient energy to release neurotransmitters from presynaptic to 
postsynaptic vesicles [5].
Beyond the mitochondria’s role in energy production, it is also a key regulator 
of apoptotic cell death [6]. Various proteins, such as cytochrome c, reside in the 
mitochondria and participate in apoptotic pathways. In normal physiological condi-
tions, cytochrome c plays a role as an electron carrier in the ETC. However, during 
neurotoxic conditions, permeabilization of the mitochondrial membrane occurs, 
and cytochrome c is released into the cytoplasm. Upon release, cytochrome c binds 
to apoptotic protease activating factor 1 (Apaf-1) which, in turn, activates cas-
pase-9, forming the apoptosome that then activates downstream caspases leading 
to cell death [7]. Second mitochondria-derived activator of caspase (Smac)/direct 
IAP-binding protein with low PI (DIABLO) is also a mitochondrial protein released 
during apoptosis. The N-terminus of Smac/DIABLO directly interacts with inhibi-
tor of apoptosis proteins (IAPs), a family of proteins that inhibit caspase 3, 7, and 9 
activities; thus Smac/ DIABLO exhibits pro-apoptotic roles [8].
It has been well studied that Bcl-2 family of proteins controls neuronal survival 
or death via regulating apoptotic pathways, i.e., pro-apoptotic proteins versus 
anti-apoptotic proteins [9]. The presence of at least one of the four Bcl-2 homology 
(BH) domains influences a Bcl-2 family member’s role in apoptosis. Pro-apoptotic 
Bcl-2 family members include the multidomain homology proteins such as Bax 
and Bak as well as the BH3-only homology proteins such as Bid, Bim, Bad, PUMA, 
and NOXA. These pro-apoptotic Bcl-2 proteins enhance mitochondrial membrane 
permeabilization resulting in subsequent release of cytochrome c [10–14].
Anti-apoptotic proteins of the Bcl-2 family include Bcl-2, Bcl-xL, Bcl-w, Mcl-1, 
and Bfl-1. These proteins contain the BH4 homology, which is essential for anti-
apoptotic functionality. Both Bcl-2 and Bcl-xL antagonize pro-apoptotic members 
to prevent apoptosis [15, 16]; for instance, Bcl-xL targets Bak, preventing its oligo-
merization and inhibiting it from damaging the mitochondrial outer membrane 
[17]. Similarly, the C-terminal of Bcl-xL binds to the BH3 domain of Bax, resulting 
in retro-translocation-activated Bax. [18]. Protein-protein binding is further dem-
onstrated with additional members of Bcl-2 family. These observations suggest that 
the Bcl-2 family’s role in mediating apoptosis and mitochondrial permeabilization is 
largely influenced by dynamic protein-protein interactions with each other [19–21].
The mitochondrion is also responsible for the production of reactive oxygen 
species (ROS), namely, superoxide and hydrogen peroxide, at Complex I and III 
of the ETC [22]. This occurs as a result of electron leakage from the complexes, 
which then allows oxygen to react [23]. Due to the high energy demands required 
by neuronal mitochondria, this results in increased ROS generation. Increased ROS 
activity contributes to lipid peroxidation, causing disruption of the hydrophobic 
interaction between cytochrome c and cardiolipin, thus releasing cytochrome c 
[24]. Furthermore, the brain is particularly susceptible to oxidative damage due 
to its composition of high lipid content. Indeed, ROS play a significant role in the 
regulation of cell death; however, ROS have recently been reported to induce DNA 
demethylation via 8-oxoguanine DNA glycosylase-1 (OGG1) [25]. As a result, 
DNA demethylation induces activation of the reelin gene [26], which has been 
implicated in enhancing synaptic plasticity by inducing long-term potentiation 
(LTP) [27], thus indicating that normal levels of ROS may play a role in supporting 
LTP. Additionally, elimination of ROS negatively impacted neural stem cell prolif-
eration in hippocampal cells indicating that homeostatic levels of ROS may possibly 
be involved in cell proliferation during growth and development [28]; however 
additional information is needed in order to elucidate the mechanism behind this.
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2. Mitochondrial dynamics
Mitochondria were previously thought of as static organelles. Due to advances in 
molecular biotechnologies, it has been revealed that mitochondria are indeed very 
dynamic; mitochondria undergo fission and fusion, can vary in morphology, and 
achieve intracellular movement. Precise execution of these processes is especially 
vital for proper ATP production, apoptosis, and ROS homeostasis in neurons to 
properly execute neurotransmission.
2.1 Fission and fusion
Fission and fusion are integral processes of cellular homeostasis that maintain 
proper mitochondrial morphology and turnover. Both are mediated by GTPases in 
the dynamin family, with rates of occurrence depending on changes in metabolic 
demands. Undoubtedly, fission is essential for dividing cells in order to maintain 
an adequate number of mitochondria; however, even in nonproliferating neurons, 
fission is necessary for cell survival [29]. Dynamin-related protein 1 (Drp1) is the 
primary GTPase that mediates fission, with its activity controlled by phosphoryla-
tion via kinases, primarily on two serine residues. Specifically, phosphorylation 
at Ser616 promotes fission, while phosphorylation at Ser637 inhibits fission, so 
balance of Drp1 phosphorylation is crucial for proper fission functionality [30]. 
Impairment in Drp1 leads to alterations in mitochondrial distribution, with mito-
chondria accumulation occurring at the soma and reduced density in the dendrites. 
Conversely, Drp1 overexpression yields an increase in dendritic mitochondria 
[31]. Hippocampal neurons lacking Drp1 display compromised function of axonal 
mitochondria due to the inability to maintain ATP levels, recycling at synapses 
[32]. Prominent regulators of fusion include mitofusion 1 and 2 (Mfn1 and Mfn2, 
respectively) and optic protein atrophy 1 (Opa1). Mitofusion proteins mediate the 
outer membrane, while Opa1 regulates the inner membrane; however, both work in 
coordination in a two-step process to carry out fusion [33, 34].
Both fission and fusion are enhanced by Bcl-xL, with fission being induced in a 
Drp1-dependent manner [35]. This is conclusive with a previous study demonstrat-
ing the direct interaction of Bcl-xL with Drp1, initiating Drp1-dependent synapse 
formation in hippocampal cells [36]. When investigated further, this Bcl-xL-Drp1 
complex was found to be necessary for presynaptic plasticity by regulating endo-
cytic vesicles [37].
2.2 Mitochondrial trafficking
Trafficking, mobility, and docking are intertwining processes that are vital 
to ensure neurons are equipped with the proper distribution and recycling of 
mitochondria at axons and synapses throughout the cell’s life span. Figure 1 
demonstrates how mitochondria are motile and change morphology in primary 
hippocampal cells. Mitochondrial trafficking is mediated by intracellular signal-
ing, physiological events, and alterations in metabolic demands. Approximately 
70% of mitochondria are stationary, with the remaining 30% motile [38]. 
Furthermore, five distinct mitochondria motility patterns have been described by 
Sun’s research group: stationary outside of synapses, docking at synapses, passing 
though synapses, pausing at synapses for a short amount of time, and pausing for 
a longer time [39].
Mechanisms of mitochondrial movement and transport are overall influenced 
by the polarity of axons, with the positive end directed toward the soma and the 
negative at the tips. Utilizing this consistent axonal polarity is how microtubule 
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motors drive transport in two directions. Movement away from the soma or antero-
grade movement is conducted by the ATPase family of kinesins, with kinesin-1 
being responsible for mitochondrial transport, specifically in neurons [38, 40]. 
Kinesin-1 consists of heavy chains (KHC) and light chains, with the heavy chains 
being the driving force that allows kinesin-1 to function as a motor protein [41]. 
Retrograde movement or movement toward the soma is driven by dynein. However, 
it is likely that these movements are coordinated rather than competitive toward 
each other, as it has been demonstrated that inhibiting kinesin-1 in Drosophila 
reduces retrograde movement [42].
Mitochondrial Rho-GTPase, or Miro, is an outer membrane receptor, Ca2+ 
sensor, and another pertinent regulator of mitochondrial motility due to its ability 
to anchor kinesin and dynein to the mitochondrial outer membrane [43]. Miro’s 
anchoring role has been extensively studied in anterograde movement in the motor/
adaptor complex formed between KHC and Miro, connected by the protein adaptor 
milton [44, 45].
Another important component of mitochondria trafficking is stationary dock-
ing. Mitochondrial docking is largely mediated by the axonal outer membrane pro-
tein syntaphilin (SNPH) and its interaction with microtubules in the cytoskeleton. 
This is demonstrated in rodent models in which deletion of the SNPH gene results 
in an increase in mitochondria motility and reduced density, while overexpression 
of endogenous or exogenous SNPH abolished mobility [46]. Along with decreasing 
the percentage of immobile mitochondria, loss of SNPH decreases axonal branch-
ing in cortical neurons [47]. This effect is comparable to neurons lacking LKB-1 and 
NUAK1, which is necessary for axonal specification [48]. The removal of either of 
these kinases leads to a decrease in the number of stationary mitochondria along 
with decreased branching. However, overexpression of SNPH in the LKB-1 and 
NUAK1-null neurons rescued these effects. Collectively, this implies that docking 
of mitochondria is required for axonal branching and growth [47]. Since Bcl-xL is 
required for neurite outgrowth [49], it is possible that Bcl-xL exerts this effect by 
interacting with docking proteins such as syntaphilin. However, the exact role of 
Bcl-xL in docking mechanisms must be further elucidated.
3. Alteration of mitochondrial function in brain-associated diseases
While various brain-associated diseases have different pathophysiologies, there 
is an underlying similarity that consistently occurs: mitochondrial dysfunction. 
Throughout these conditions, neurodegeneration is correlated with an energy deficit 
caused by inefficient operation of the ETC, activation of mitochondria-dependent 
apoptosis, and accumulation of ROS. In addition, excitotoxicity, which commonly 
Figure 1. 
Mitochondrial movement in primary hippocampal neurons. Primary hippocampal neurons were labeled with 
mitoRFP, a red fluorescent tag that labels mitochondria. Micrographs were taken at 3 and 4 weeks after seeding. 
Morphology and location of mitochondria change over time.
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occurs during cerebral ischemia and traumatic brain injury, impairs homeostasis of 
excitatory neurotransmitter glutamate [50–53]. Overstimulation of glutamate recep-
tors further leads to Ca2+ release; because mitochondria are one of the key regulators 
of Ca2+, excessive influx can consequently lead to mitochondrial dysfunction, altered 
membrane permeabilization, and subsequent cell death [50, 54–56]. Pathways 
such as these have been extensively explored in neurological conditions. However, 
research in the past decade has begun to determine the relationship between brain-
associated conditions and mitochondrial dynamics.
3.1 Parkinson’s disease
Parkinson’s disease (PD) is a common neurodegenerative disease that has detri-
mental clinical effects including tremors, impaired gait, and stiffness of limbs [57]. 
These symptoms are often due to PD’s hallmark characterization of degeneration of 
the dopaminergic neurons in the substantia nigra. Individuals with PD are vulner-
able to increased ROS production due to reduced complex 1 activity, increased lipid 
oxidation, and altered antioxidant systems [58].
As several PD-specific proteins impact mitochondrial dynamics, it is possible 
that the neurodegeneration that occurs with PD is linked to alterations in fis-
sion and fusion [59, 60]. Dopaminergic neurons depleted of Drp1 demonstrated 
decreased mitochondrial mass, impaired motility, and overall neuron loss. Neurons 
depleted with Drp1 had less mitochondria in the soma and were almost completely 
depleted from the axons; by not having mitochondria at axons, this can lead to the 
neurodegeneration due to energy deficits, as synaptic transmission requires a high 
demand of ATP [61].
The PINK1/Parkin pathway has been traditionally studied with its roles in 
mitophagy. Under normal physiological conditions, PINK1 accumulates on the 
surface of dysfunctional mitochondria to signal Parkin translocation to initiate 
ubiquitination [62]. However, mutations in PINK1 and Parkin, which have been 
linked to early onset familial forms of PD, lead to loss of mitochondrial membrane 
potential, leading to impairment of Parkin’s translocation and thus accumulation 
of dysfunctional mitochondria [63]. Research in recent years has begun to uncover 
the role of the PINK1/Parkin pathway in mitochondrial transport. Overexpression 
of PINK1 phosphorylates Miro, targeting it for ubiquitination and subsequent 
degradation. This results in the dismantling of the motor/adaptor complex, releas-
ing kinesin and milton from the mitochondrial surface, and leads to halting of 
mitochondrial motility [64]. It is possible that this system may promote neuropro-
tection by preventing anterograde transport of mitochondria and allowing PINK1 
to accumulate on damaged mitochondria to initiate mitophagy [65]. Furthermore, 
PINK1 may exert neuroprotection due to its interaction with Bcl-xL [66]. It has 
been shown that PINK1 phosphorylates Bcl-xL at its Ser62; as a result, this prevents 
N-terminal cleavage of Bcl-xL or formation of ΔN-Bcl-xL, which has been associ-
ated with neuronal death [67–69]. However, if altered PINK1 expression occurs as 
a result of genetic mutation, this may lead to dysregulated mitochondrial transport 
and promotion of apoptosis.
The presynaptic protein α-synuclein is a major constituent of Lewy bodies, 
with mutations in its encoding gene, SNCA, being linked to familial PD [70]. Some 
amount of α-synuclein can localize to the mitochondria, inducing mitochondrial 
fragmentation, dysfunction, and downregulation of complex 1 activity, potentially 
contributing to ROS production [71]. Overexpression of α-synuclein results in 
cytotoxicity due to decreased Bcl-xL expression and increased Bax expression 
[72]. Shaltouki’s research group recently investigated the role of α-synuclein on 
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mitochondrial dynamics by using multiple PD models. In the postmortem brains of 
humans with PD, it was observed that protein levels of α-synuclein and Miro were 
highly upregulated compared to the control brains, while KHC, VDAC, and Mfn2 
remained unchanged. Additionally, the β-subunit of ATP synthase was upregu-
lated in the PD brains. When this was further explored in human cell lines and in 
Drosophila bearing SNCA mutations, neurodegeneration and locomotion defects 
occurred as a result of the upregulated α-synuclein and subsequent upregulation 
of Miro. These effects were rescued with a partial reduction of Miro. Interestingly, 
upregulation of Miro led to delayed mitophagy implying that α-synuclein’s impact 
on Miro is probably independent of the PINK1/Parkin pathways [73].
Recently, it was shown that the β-subunit of ATP synthase binds to DJ-1 suggest-
ing that DJ-1 plays a role in increasing ATP efficiency [74]. Mutations in DJ-1 also 
demonstrate inefficient ATP production, alterations in mitochondrial morphology, 
and enhanced membrane permeability [74–76]. Although its functions are not com-
pletely understood, DJ-1 has been noted to prevent the aggregation of α-synuclein 
[77]. As Lewy bodies in PD are primarily a result of α-synuclein aggregation, 
inhibiting this aggregation may consequently delay Lewy body formation. Thus, 
therapies targeting DJ-1 may serve as a multi-faceted mechanism for PD treatment.
3.2 Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disease and 
the leading cause of dementia worldwide [78]. Two hallmark characteristics of AD 
are the presence of amyloid-beta peptide (Aβ) plaques and tau protein tangles. The 
formation of Aβ occurs as a consequence of cleavage of amyloid precursor protein 
(APP), where Aβ peptides can then aggregate into oligomers or fibrils [79]. In the 
brain, the typical role of tau proteins is to stabilize microtubules; however, in AD, it 
is suspected that hyperphosphorylation of tau leads to the formation of neurofibril 
tangles [80]. Both Aβ and tau tangles can cause impairments or interruptions in 
pathways essential for neuronal survival.
Reduced transport of axonal mitochondria has been documented in subjects with 
AD, but there may be multiple mechanisms to cause this disruption [81]. The presence 
of Aβ reduces bidirectional axonal mitochondrial motility but has a more significant 
impact on anterograde movement versus retrograde [82, 83]. This may be because Aβ 
activates GSK-3β, which is a negative regulator of kinesin-1. Phosphorylation of kine-
sin-1 by GSK-3β can lead to a reduction in mitochondria density [84]. Furthermore, 
mutations in presenilin-1 (PS1), which is linked to familial AD, promote GSK-3β-
mediated kinesin-1 phosphorylation and reductions of anterograde mitochondria 
transport [84]. Overexpression of tau also has the ability to redirect mitochondrial 
transport; kinesin-1 encounters tau and is detracted from microtubule tracks, slowing 
down anterograde movement and increasing the favorability of dynein-mediated ret-
rograde movement [85, 86]. Abnormal fission mechanics have also been observed in 
AD as a result of alteration in Drp1 function. Neurotoxicity via tau interrupts fission, 
causing elongated mitochondria and mislocalization of Drp1. This occurs because 
hyperphosphorylation of tau causes disruptions in actin, preventing actin-based 
translocation of Drp1 to the mitochondria [87].
3.3 Stroke
Cerebral ischemia, or more commonly stroke, is characterized by the decrease or 
cessation of blood flow to the brain. Consequently, the loss of oxygen and nutrients 
to neurons causes ATP deficits, apoptosis, and Ca2+ influx. It is not surprising 
then that mitochondrial dynamics are influenced after ischemic events. This is 
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demonstrated by Zou’s research group as they sought to elucidate how mechanisms 
of fission and mitophagy are impacted after ischemia [88]. Using a model of middle 
cerebral artery occlusion (MCAO), Drp1 initially increased but then decreased, 
implying that ischemia induced fission, but the process was disrupted due to abnor-
malities in translocation of Drp1 caused by MCAO. Mitophagy is also selectively 
induced by mild ischemia in a Drp1-dependent manner; this is evident by increased 
expressions of LC3B and Beclin-1 and decreased p62. Moreover, inhibition of Drp1 
led to early onset of apoptotic pathways [88]. This may be supported by transient 
ischemia models, in which p-Drp1 is upregulated [89, 90]. Interestingly, evidence 
shows that p-Drp1 at Ser616 may be regulated by PINK1, establishing a link between 
fission and mitophagy [90]. Like fission, mechanisms of fusion are also impacted 
by ischemic insult. Mfn2 expression is decreased after MCAO and leads to apopto-
sis, but when overexpressed, Mfn2 shows an anti-apoptotic effect by modulating 
Bcl-2 and Bax [91]; these results are conclusive with a similar study, showing that 
Mfn2 expression is decreased after excitotoxic insult with a subsequent increase in 
Bax translocation to the mitochondria [92].
Excitotoxicity via overactivation of glutamate receptors, namely, N-methyl-D-
aspartate (NMDA) receptors (NMDARs), is a key player of neuronal death after 
cerebral ischemia [93]. Thus, uncovering mechanisms effecting NMDARs is an 
attractive idea for therapeutic agents. While mechanisms of mitochondrial motility 
are less investigated in models of cerebral ischemia, a recent study has elucidated a 
novel role of kinesin-1 transport. The heavy chain of kinesin-1 has been shown to 
bind directly to NMDARs, mediating their transport. By either disassociating this 
bond or suppressing kinesin-1 expression, this can improve Ca2+ influx and NMDA 
excitotoxicity resulting from ischemia [94].
3.4 Traumatic brain injury (TBI)
Reducing excessive fission that occurs post-TBI is a potential target of neu-
roprotection to prevent neuronal impairments and death. In rodent models, TBI 
causes an increase in translocation of Drp1 to the mitochondria, increasing rates 
of fission. Consequently, this led to neuronal apoptosis, decreased neurogenesis, 
impaired cognition, and memory defects. When administered with Mdivi-1, a 
pharmacological inhibitor of Drp1, these negative effects were attenuated, confirm-
ing the role of increased Drp1 activity [95, 96]. Interestingly, Pietro’s research group 
suggest that many molecular responses after severe TBI are opposite from that of 
mild TBI. Rodents with severe TBI presented with activation of fission as shown 
by overexpression of Drp1 and FIS1, a protein that binds to Drp1 for anchoring to 
the mitochondrial outer membrane. Furthermore, expressions of Mfn1 and Mfn2 
were downregulated, and there were no changes in Opa1 gene and protein expres-
sions, demonstrating an inhibition of fusion as a result of severe TBI. Additionally, 
the increase of dysfunctional mitochondria led to a subsequent overexpression 
of PINK1 and PARK2, triggering mitophagy. Conversely, mild TBI demonstrated 
activation of fusion with inhibition of fission; together, this did not change PINK1 
or PARK2 gene expressions, thus showing no difference in mitophagy [97].
4. The effect of lifestyle factors on mitochondria function and dynamics
4.1 Exercise and mitochondria
Traditionally observed at a large, systemic level, research in recent years has 
begun to investigate the effect of exercise on mitochondrial function and dynamic 
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processes. Furthermore, encouraging results have been observed by analyzing these 
effects in physiological processes in the brain and pathological conditions such as 
Alzheimer’s disease and Parkinson’s disease [98–101]. After old and young mice 
were subjected to 6 weeks of treadmill exercise, old mice were found to respond 
positively, showing attenuated activity of coupled complexes I–III of the ETC [99].
Exercise regulates mitochondrial fission and fusion proteins such as Opa1, Mfn2, 
and Drp1 and enhances mitochondrial biogenesis via upregulation of mitochondrial 
DNA. This suggests a role for exercise in maintaining a healthy population of mito-
chondria [98, 101]. In addition, rodents that undergo physical exercise demonstrate 
improved cognitive and exploratory behaviors along with improved mitochondrial 
redox homeostasis and mitochondria-mediated brain energy metabolism [102–104].
Exercise has been shown to regulate apoptosis through the regulation of the 
Bcl-2 family in various models and tissues. As previously discussed, age can have 
a significant role in mitochondrial dysfunction. A study conducted by Kim et al. 
investigated how hippocampal neurogenesis and apoptosis were affected by tread-
mill exercise in young and old-aged rats [105]. Expressions of caspase-3, Bax, Bid, 
and Bcl-2 were all increased in old mice. After being subjected to treadmill exercise 
for 30 minutes, once per day for 6 weeks, old rats exhibited further enhancement 
of Bcl-2 expression, along with decreased expressions of caspase-3, Bax, and Bid. 
Interestingly, exercise did not impact expressions of Bcl-2, Bax, or caspase-3 in 
young mice. These results implicate that aerobic exercise may be especially impor-
tant during aging to exert neuroprotective properties. Aboutaleb et al. examined 
the effect exercise had on the ratio of Bax/Bcl-2 proteins in hippocampal CA3 cells 
after ischemia. Ischemic insult led to an increase in caspase-3 and decrease in Bcl-2, 
thus an increase in Bax/Bcl-2 ratio. However, rats pre-subjected to exercise showed 
reduced levels of caspase-3 and attenuation of Bax/Bcl-2 ratio [106]. Similar results 
have been seen in a rodent TBI model, in which treadmill exercise lowered the Bax/
Bcl-2 ratio and decreased the levels of active caspase-3 [107]. Likewise, endurance 
exercise exerted neuroprotection in PD models by modulation of Mcl-1, Bcl-2, and 
apoptosis-inducing factor [108]. Although Bcl-2 has primarily been investigated in 
rodent exercise models, exercise results in a negative regulatory effect on caspase-3 
[105–107] which may reduce post-translational cleavage of Bcl-xL supporting 
neuronal survival [67, 69].
Since the Bcl-2 family proteins are present in the mitochondria throughout 
all tissue types, it is plausible that protective effects observed in non-neuronal 
mitochondria are indeed simultaneously occurring in neuronal mitochondria. For 
example, due to the correlation between diabetes and cardiovascular disease, Cheng 
et al. examined the relationship between apoptosis, cardiomyocytes, and aerobic 
exercise in streptozotocin (STZ)-induced diabetic rats. The STZ rats had signifi-
cantly lower amounts of Bcl-2, Bcl-xL, and p-Bad and higher levels of caspase-3 
than controls. However, these levels were all rescued when subjected to aerobic 
exercise [109]. These results implicate the ability of aerobic exercise to regulate 
apoptosis and exert cellular protection, even during chronic conditions.
4.2 Non-neurological conditions and mitochondrial consequences
As chronic diseases such as diabetes and obesity become more prevalent world-
wide, research is uncovering the relationship between traditional non-neurological 
and brain-associated diseases. However, many interventions in studies concerning 
chronic diseases observe outcomes on a macrolevel and may not consider molecular 
effects. For these reasons, it is important to uncover how these non-neurological 
chronic conditions are impacting the mitochondria. By elucidating these 
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mechanisms, this can serve as an additional, albeit perhaps overlooked, means of 
prevention against brain pathology.
Besides disrupting the uptake of glucose, diabetes can also damage the function, 
population, and morphology of mitochondria in neurons, potentially contribut-
ing to impaired cognition later in life [110–113]. Metabolic pathways that can lead 
to energy failure in mitochondria as well as prevent antioxidant interception are 
affected by diabetes. In the diabetic brain, mitochondrial perturbation can result in 
a lack of neuronal energy that will alter synaptic function and eventually cause the 
neurons to degenerate [114]. The effect of energy impairments is demonstrated in a 
cross-sectional study in which adolescents with type 2 diabetes had slower conver-
sion rates of ADP to ATP than obese and lean controls. The explanation for this 
effect was suspected to be due to decreased blood flow, thus causing alterations in 
oxygen delivery [115]. Studies have shown that diabetes can modify fission mecha-
nisms in rodent models. Although amounts of Mfn1 and Opa1 remain unchanged 
during diabetes, Drp1 mRNA is increased. Furthermore, there is an increase of 
translocation of Drp1 to the mitochondria in diabetes [110, 113]. This increase in 
translocation is due to GSK3β-mediated phosphorylation at Ser616 of Drp1. The 
combination of unchanged Mfn1 and Opa1 with increased Drp1 proposes that the 
disproportion between fission and fusion proteins contributes to mitochondrial 
dysfunction in rats with diabetes. This was further evident by altered mitochon-
drial morphology and density. Elevated levels of Drp1 can lead to mitochondrial 
fragmentation that is conducive to damage in the synapses of neurons, contributing 
to impairments in learning and memory [116]. Beyond alterations in fission and 
fusion, decreased ATP production and activity of complex I were observed in the 
diabetic hippocampus. Moreover, glutathione and ascorbate levels were decreased, 
suggesting that diabetes impairs mitochondrial antioxidant systems [110]. These 
results are supported by a study that found decreased coenzyme Q9 and ATPase 
activity in the mitochondria of diabetic rats [117].
Obesity is known to increase the risk of developing diabetes, cardiovascular 
disease, and neurological conditions. Indeed, obese animal models are often utilized 
to study insulin resistance. A characteristic of obesity is chronic inflammation 
and oxidative stress, so it is not surprising that mitochondrial dysfunction occurs 
throughout the body, including the brain [114]. Specifically, brain mitochondria 
of obese rats induced via a high-fat diet have repeatedly demonstrated a shift to 
pro-apoptotic pathways, as shown by elevated Bax expressions, lowered Bcl-2, and 
a higher Bax/Bcl-2 ratio [118, 119]. The detrimental effects of obesity continue to 
be demonstrated in the brain by upregulating production of ROS and alteration of 
mitochondrial membrane potential [120–122].
4.3 Diet and mitochondria
Diet, including intake of specific nutrients and overall encompassing dietary 
patterns, is a driver of maintaining cellular processes throughout the body. 
Treatment of diseases via diet is appealing due to the ability of nutrients to cross the 
blood brain barriers and ease of accessibility. Specifically, it is important to consider 
how an individual’s overall dietary pattern impacts cellular processes. Dietary 
patterns, including composition of macronutrients and caloric provision, have been 
studied regarding efficacy in neuroprotection [123–125].
Caloric restriction has been implicated in the protection against several patho-
logical brain conditions in various animal models such as AD and PD and under 
conditions of excitotoxicity [126–130]. Caloric restriction has been shown to con-
fer protection from neurodegeneration by improving mitochondrial redox status 
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by reducing ROS production localized to complex I of the ETC [131]. Recent evi-
dence suggests that caloric restriction may prevent formation of ROS via upregu-
lation of antioxidants such as mitochondrial superoxide dismutase 2 (SOD2) and 
glutathione [132]. Caloric restriction has also been reported to upregulate antioxi-
dants localized to the plasma membrane such as coenzyme Q10 and α-tocopherol 
via an increase in redox enzymes that are capable of reducing these molecules 
back to their antioxidant form [133]. Due to coenzyme Q10’s pivotal role as an 
electron carrier in the ETC, we speculate that caloric restriction may be benefi-
cial to maintain redox balance in the mitochondrial membrane. Additionally, 
mRNA expressions of Bcl-2 and Bcl-xL were also reported to be upregulated 
in the ipsilateral cortex region of mice placed on caloric restriction against TBI 
[134], indicating that caloric restriction may prevent TBI-induced neuronal loss. 
Furthermore, caloric restriction improves mitochondrial function by enhancing 
ATP levels in aging mice [135]. Mice placed on caloric restriction for 6 months 
had increased mitochondrial biogenesis and increased levels of cytochrome c 
oxidase and citrate synthase activity, enhancing mitochondrial respiration [136]. 
Caloric restriction may enhance mitochondrial metabolism by also upregulating 
the activity of complexes I, III, and IV [128]. Interestingly, recent evidence shows 
that caloric restriction enhances expression of brain-derived neurotrophic factor 
(BDNF) [137, 138], which has been reported to regulate mitochondrial mobility 
and enhance presynaptic docking [139]. However, the mechanisms of how caloric 
restriction mediates BDNF expression are still unclear. Clinical trials in which 
older adults are placed on caloric restriction consistently yield positive results, 
such as improved memory and enhanced gray matter [140, 141]. Additionally, 
caloric restriction attenuated behavioral dysfunction in a model of PD in adult 
rhesus monkeys [130]. Taken together, these studies point toward caloric restric-
tion mediating biological markers of chronic disease such as oxidative stress and 
supporting mitochondrial function by enhancing ATP metabolism and possibly 
lessening clinical symptoms associated with neurodegeneration.
The ketogenic diet, popular for its high-fat and very low carbohydrate pattern, 
has recently been implicated in protection of the brain through apoptotic path-
ways. Various mammalian animals placed on the ketogenic diet show decreased 
rates of apoptotic stimuli in neuronal cells via downregulation of mitochondrial 
cytochrome c release and active caspase-3 both in seizures [142, 143] and TBI 
models [144], respectively. The decrease in translocation of cytochrome c from 
the mitochondria to the cytosol may be through the regulation of Bcl-2. One study 
found that both a high carbohydrate and a high ketogenic diet upregulate Bcl-2 in 
cortical neurons after focal cerebral ischemia; however, the ketogenic diet displayed 
higher upregulation [145], indicating that the ketogenic diet may be more efficient 
in regulating apoptosis than a high carbohydrate diet. The ketogenic diet may 
play an additional role in cell death and survival pathways, as it has been noted to 
protect hippocampal cells from death by preventing the interaction between Bad 
and Bcl-xL [146]. The ketogenic diet further supports neuronal energy metabolism 
by maintaining mitochondrial morphology, enhancing biogenesis of mitochondria, 
and improving mitochondrial respiration [147–151]. After neurotoxic insult, the 
ketogenic diet enhanced complex I-driven oxygen consumption and prevented loss 
of complex II–III function, implicating the ketogenic diet’s ability to improve the 
activity of the ETC [147, 149]. Likewise, the ketogenic diet attenuates mitochondrial 
oxidative stress levels in both in vitro and in vivo model, which prevents energy 
deficit associated with brain cell damage [147, 149, 151]. Interestingly, the ketogenic 
diet has also been shown to upregulate Beclin-1 [142] and Drp1 [148], suggesting 
that the ketogenic diet may be able to control mitochondrial population by regulat-
ing autophagy and mitochondrial fission, respectively.
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5. Conclusions
Mitochondria are well established in their role with ATP production, apoptosis, 
ROS homeostasis, and intracellular ion signaling. Research in recent years has 
recognized that proper execution of these processes is reliant on the mitochondria’s 
dynamic capabilities. In this chapter we have discussed mechanisms of mitochon-
drial morphology, degradation, and trafficking, as well as the relationship between 
these processes and pathological brain conditions. Utilizing lifestyle factors, such 
as exercise and diet, can serve as a neuroprotective strategy by targeting neuronal 
mitochondrial dynamics. Implementing lifestyle changes serves as an accessible 
treatment that is easily translated from bench to bedside.
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